Toronto - Delayed Quote CAD
Satellos Bioscience Inc. (MSCL.TO)
At close: October 18 at 3:54 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-22,225.0000
-14,501.0000
-5,783.0000
-5,033.7110
-1,659.9820
Investing Cash Flow
-17,278.0000
-17,538.0000
-3.0000
1,738.1760
--
Financing Cash Flow
-2,003.0000
51,033.0000
2,775.0000
7,450.7120
1,978.3830
End Cash Position
7,221.0000
22,067.0000
1,924.0000
4,871.2630
717.5300
Capital Expenditure
-17.0000
-18.0000
-3.0000
-7.2460
--
Issuance of Capital Stock
--
32,463.0000
2,775.0000
7,078.6760
890.5410
Issuance of Debt
-1.0000
2,244.0000
--
186.5730
1,087.8420
Repayment of Debt
--
-2,528.0000
--
--
--
Free Cash Flow
-22,242.0000
-14,519.0000
-5,786.0000
-5,040.9570
-1,659.9820
12/31/2020 - 1/7/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APLI.TO Appili Therapeutics Inc.
0.0400
+14.29%
MDNA.TO Medicenna Therapeutics Corp.
2.2800
-3.39%
BCT.TO BriaCell Therapeutics Corp.
1.1600
0.00%
HBP.TO Helix BioPharma Corp.
1.1300
-8.13%
MBX.TO Microbix Biosystems Inc.
0.3350
0.00%
APLIF Appili Therapeutics Inc.
0.0250
-4.58%
EPRX.TO Eupraxia Pharmaceuticals Inc.
3.5000
+0.86%
SVA.TO Sernova Corp.
0.2650
0.00%
MDMA.CN Pharmala Biotech Holdings Inc.
0.1450
+3.57%
EPRX Eupraxia Pharmaceuticals Inc.
2.5100
-1.57%